Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Income from Non-Controlling Interests (2024 - 2025)

Coeptis Therapeutics Holdings (COEP) has 2 years of Income from Non-Controlling Interests data on record, last reported at $159360.0 in Q3 2025.

  • For Q3 2025, Income from Non-Controlling Interests changed N/A year-over-year to $159360.0; the TTM value through Sep 2025 reached $2.3 million, changed N/A, while the annual FY2024 figure was $1.1 million, N/A changed from the prior year.
  • Income from Non-Controlling Interests reached $159360.0 in Q3 2025 per COEP's latest filing, down from $799991.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $961710.0 in Q4 2024 and bottomed at $159360.0 in Q3 2025.